Specifically, PLEKHA4 expression was significantly elevated in CHOL, diffuse large B-cell lymphoma (DLBC), GBM, KIRC, KIRP, LGG, pancreatic adenocarcinoma (PAAD), skin cutaneous melanoma (SKCM), STAD, testicular germ cell tumors (TGCT), THCA, and thymoma (THYM). Here, PLEKHA4 is linked to pancreatic adenocarcinoma.